ISOPT Clinical 2013 - International Symposium on Ocular Pharmacology and Therapeutics
March 7 - 10, 2013
Marriott Rive Gauche Hotel & Conference Center
Paris, France
Paris, France
The International Symposium on Ocular Pharmacology and Therapeutics (ISOPT) covers topics such as:
- Inflammation & Infection
Treatment Updates, Allergic Conjunctivitis, Cases Presentation, Clinical Studies for Uveitis and Ocular Infections - Retina
Wet AMD, Dry AMD, Diabetic Macular Edema, Diabetic Retinopathy, Retinal Degeneration, Retinal Vein Occlusion and Devices & Drug Delivery - Glaucoma
Glaucoma Therapy & Ocular Surface, Conventional & Potential Glaucoma Therapy, Blood Flow & Glaucoma and Inraocular Pressure & Glaucoma - Basic Science
Inhibition of Diabetic Retinopathy, Therapy of Neovascularization, Vascular Targets, Antioxidants and Nutrition and Gene Therapy - Drug Development
Imaging, Drug Delivery, Nano Technology, Toxicology, Ethics and Regulation of Ophthalmic Products - External Eye Diseases
Dry Eye-Ocular Surface Clinical Trials, Dry Eye Treatment Innovations, External Eye Diseases, Wound Healing, Devices and Anterior Segment Imaging
Address
17 Boulevard Saint Jacques,
Paris,
France
Paris,
France
Prices *
270-650 Euro (Early registration date: December 19, 2012)
Exhibition
Included
Abstract submission deadline
December 4, 2012
Organization
Website
Categories
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Medical Seminars for All in the Field
- Correlation existing between the decreasing values of central corneal thickness and worsening of the field defect in primary open angle glaucoma (Health/Opthalmology)
- Mechanisms of hearing loss in prematures and fullterms with perinatal or postnatal hypoxia
- Validation of Palliative Prognostic Index for Terminal Cancer Patients in Hospice Consultation Setting in Taiwan
- Corneal endothelial recovery in patients undergoing small incision cataract surgery comparison between diabetics and non diabetics.
- Effect of pegylated interferon and ribavirin used for treatment of chronic hepatitis C patients on semen parameters
